雷巴米皮德用于治疗甲状腺引起的口腔:一个三臂随机临床试验
Amira Abdelaziz1, Rehab Nabil Shamma2, Hala Lotfy Fayed3
1Department of Oral Medicine and Periodontology, Faculty of Dentistry, Cairo University, Giza, Egypt.
Clinical oral investigations
|February 1, 2025
概括
局部Rebamipide,在正规和纳米颗粒形式,有效地管理了类风湿性关节炎患者的口腔. 它显示了与克洛贝塔索酸相似的结果,提供了一个有前途的替代治疗方法.
科学领域:
- 类风湿病学 类风湿病学
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲托雷克萨特是一种常见的治疗类风湿性关节炎.
- 甲托雷克萨特可以引起口腔,影响患者的生活质量.
- 对这些的有效管理至关重要.
研究的目的:
- 为了比较局部Rebamipide (普通和纳米颗粒) 与克洛贝塔索酸盐.
- 为了评估甲索特雷克萨特诱导的口腔的治疗疗效.
- 评估类风湿性关节炎患者的结果.
主要方法:
- 随机对照试验 (RCT) 有三个臂:1%的rebamipide,1%的纳米颗粒的rebamipide和克洛贝塔索酸盐.
- 结果措施包括世卫组织口腔粘膜炎分级,疼痛 (数值评分表),的大小和愈合时间.
- 进行了统计分析以确定显著性.
主要成果:
- 所有组都显示出粘膜炎等级和疼痛减轻的显著改善.
- 在组间比较中,没有发现两组之间的显著差异.
- 纳米颗粒Rebamipide显示了领先的趋势,所有参与者更早地实现了完全治愈.
结论:
- 局部Rebamipide (常规和纳米颗粒) 证明了与克洛贝塔索酸相比的有效性.
- 雷巴米皮德 (Rebamipide) 是一种有效且有前途的替代药物,可用于治疗甲醇引起的口腔.
- 这为类风湿性关节炎患者提供了有价值的治疗选择.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
01:26Peptic Ulcer Disease IV: Management
60
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
60
01:29Drugs for Treatment of Ulcerative Colitis in IBD
118
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
118
01:29Inflammatory Bowel Disease IV: Pharmacological Management
100
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
100